Tepotinib in patients with MET exon 14 (METex14) skipping NSCLC: Analysis of all patients from VISION Cohorts A and C Meeting Abstract
| Authors: | Itchins, M.; Thomas, M.; Garassino, M.; Felip, E.; Sakai, H.; Le, X.; Veillon, R.; Smit, E.; Mazieres, J.; Cortot, A.; Raskin, J.; Viteri, S.; Yang, J.; Ahn, M. J.; Wu, Y. L.; Ma, R.; Zhao, J.; O'Brate, A.; Berghoff, K.; Bruns, R.; Otto, G.; Paik, P. |
| Abstract Title: | Tepotinib in patients with MET exon 14 (METex14) skipping NSCLC: Analysis of all patients from VISION Cohorts A and C |
| Meeting Title: | 49th Annual Scientific Meeting of the Clinical Oncology Society of Australia (COSA) |
| Journal Title: | Asia-Pacific Journal of Clinical Oncology |
| Volume: | 18 |
| Issue: | Suppl. 3 |
| Meeting Dates: | 2022 Nov 2-4 |
| Meeting Location: | Brisbane, QLD, Australia |
| ISSN: | 1743-7555 |
| Publisher: | Wiley Blackwell |
| Date Published: | 2022-11-01 |
| Start Page: | 160 |
| End Page: | 162 |
| Language: | English |
| ACCESSION: | WOS:000871956500247 |
| PROVIDER: | wos |
| DOI: | 10.1111/ajco.13869 |
| Notes: | Meeting Abstract: 279 -- This meeting abstract was published under the "Poster Abstracts" section of the issue -- Source: Wos |
